Page 141 - Read Online
P. 141
Page 14 of 15 Turati et al. Hepatoma Res 2022;8:19 https://dx.doi.org/10.20517/2394-5079.2021.130
Consent for publication
Not applicable.
Copyright
© The Author(s) 2022.
REFERENCES
1. Banales JM, Cardinale V, Carpino G, et al. Expert consensus document: Cholangiocarcinoma: current knowledge and future
perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat Rev
Gastroenterol Hepatol 2016;13:261-80. DOI PubMed
2. Valle JW, Kelley RK, Nervi B, Oh D, Zhu AX. Biliary tract cancer. Lancet 2021;397:428-44. DOI PubMed
3. Mosconi S, Beretta GD, Labianca R, Zampino MG, Gatta G, Heinemann V. Cholangiocarcinoma. Crit Rev Oncol Hematol
2009;69:259-70. DOI PubMed
4. Tyson GL, El-Serag HB. Risk factors for cholangiocarcinoma. Hepatology 2011;54:173-84. DOI PubMed PMC
5. Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet 2014;383:2168-79. DOI PubMed PMC
6. Wongjarupong N, Assavapongpaiboon B, Susantitaphong P, aet al. Non-alcoholic fatty liver disease as a risk factor for
cholangiocarcinoma: a systematic review and meta-analysis. BMC Gastroenterol 2017;17:149. DOI PubMed PMC
7. Choi J, Ghoz HM, Peeraphatdit T, et al. Aspirin use and the risk of cholangiocarcinoma. Hepatology 2016;64:785-96. DOI PubMed
PMC
8. Banales JM, Marin JJG, Lamarca A, et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev
Gastroenterol Hepatol 2020;17:557-88. DOI PubMed PMC
9. Shaib Y, El-Serag HB. The epidemiology of cholangiocarcinoma. Semin Liver Dis 2004;24:115-25. DOI PubMed
10. Ellington TD, Momin B, Wilson RJ, et al. Incidence and mortality of cancers of the biliary tract, gallbladder, and liver by sex, age,
race/ethnicity, and stage at diagnosis: united states, 2013 to 2017. Cancer Epidemiol Biomarkers Prev 2021;30:1607-14. DOI
PubMed
11. Gad MM, Saad AM, Faisaluddin M, et al. Epidemiology of cholangiocarcinoma; united states incidence and mortality trends. Clin Res
Hepatol Gastroenterol 2020;44:885-93. DOI PubMed
12. Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ. Cholangiocarcinoma - evolving concepts and therapeutic strategies. Nat Rev
Clin Oncol 2018;15:95-111. DOI PubMed PMC
13. Welzel TM, McGlynn KA, Hsing AW, O’Brien TR, Pfeiffer RM. Impact of classification of hilar cholangiocarcinomas (Klatskin
tumors) on the incidence of intra- and extrahepatic cholangiocarcinoma in the United States. J Natl Cancer Inst 2006;98:873-5. DOI
PubMed
14. Florio AA, Ferlay J, Znaor A, et al. Global trends in intrahepatic and extrahepatic cholangiocarcinoma incidence from 1993 to 2012.
Cancer 2020;126:2666-78. DOI PubMed PMC
15. Saha SK, Zhu AX, Fuchs CS, Brooks GA. Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the
rise. Oncologist 2016;21:594-9. DOI PubMed PMC
16. Kim D, Konyn P, Cholankeril G, Bonham CA, Ahmed A. Trends in the mortality of biliary tract cancers based on their anatomical site
in the United States from 2009 to 2018. Am J Gastroenterol 2021;116:1053-62. DOI PubMed
17. Van Dyke AL, Shiels MS, Jones GS, et al. Biliary tract cancer incidence and trends in the United States by demographic group, 1999-
2013. Cancer 2019;125:1489-98. DOI PubMed PMC
18. Patel N, Benipal B. Incidence of cholangiocarcinoma in the USA from 2001 to 2015: a us cancer statistics analysis of 50 states. Cureus
2019;11:e3962. DOI PubMed PMC
19. Bertuccio P, Malvezzi M, Carioli G, et al. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma. J Hepatol
2019;71:104-14. DOI PubMed
20. World Health Organization. WHO mortality database. Available from: https://www.who.int/data/data-collection-tools/who-mortality-
database [Last accessed on 2 Apr 2022].
21. World Health Organization. WHO mortality database. Available from: https://www.who.int/data/data-collection-tools/who-mortality-
database [Last accessed on 7 Apr 2022].
22. Pan American Health Organization (PAHO). Core indicators dashboard. Available from: https://opendata.paho.org/en/core-
indicators/core-indicators-dashboard [Last accessed on 7 Apr 2022].
23. Smith PG. Cancer Incidence in Five Continents. Comparison between registries: age-standardized rates. IARC Sci Publ ;1992:856-70.
PubMed
24. National Cancer Institute. Joinpoint trend analysis software. Available from: https://surveillance.cancer.gov/joinpoint/ [Last accessed
on 2 Apr 2022].
25. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med
2000;19:335-51. DOI PubMed
26. Welzel TM, Graubard BI, El-Serag HB, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a